Zacks Investment Research on MSN
Here's why Haemonetics (HAE) is a strong value stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...
Zacks Investment Research on MSN
Why Haemonetics (HAE) is a top momentum stock for the long term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Currently priced at approximately $80.53 per share, Haemonetics (NYSE: HAE) is trading roughly 7.6% below its 52-week high. Do you believe HAE stock represents a solid long-term investment at its ...
The London Company, an investment management company, released “The London Company Small Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities ...
We recently published a list of 11 Best Russell 2000 Stocks to Buy According to Wall Street Analysts. In this article, we are going to take a look at where Haemonetics Corporation (NYSE:HAE) stands ...
Detailed price information for Haemonetics Corp (HAE-N) from The Globe and Mail including charting and trades.
Haemonetics Corporation (NYSE: HAE) reported upbeat earnings for its third quarter on Thursday. The company posted quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $1 ...
Detailed price information for Haemonetics Corp (HAE-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results